7-5528536-G-C
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM5PP2PP3_StrongPP5_Moderate
The NM_001101.5(ACTB):c.547C>G(p.Arg183Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R183W) has been classified as Pathogenic.
Frequency
Consequence
NM_001101.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 70
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
ACTB-related disorder Pathogenic:1
The ACTB c.547C>G (p.Arg183Gly) variant is a missense variant. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. This variant is not found in the Genome Aggregation Database in a region of good sequence coverage, so the variant is presumed to be rare. A different variant affecting the same amino acid residue, p.Arg183Trp, has been reported in at least seven individuals with dystonia, hearing loss and variable additional features (Skogseid et al. 2018). Based on the identification of the variant in a de novo state, its rarity, and literature evidence, the p.Arg183Gly variant is classified as likely pathogenic for ACTB-related disorders. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at